SCHEMBL16339859

SCHEMBL16339859

CCOc1cc(N2CCNCC2)ncc1C(=O)Nc1cc(F)c2nc(C)cn2c1.COc1cc(N2CCNCC2)ncc1C(=O)Nc1cc(F)c2nc(C)cn2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 2/20 0.39
▸ JAK3 P52333 1/20 0.39
▸ BTK Q06187 1/20 0.39
▸ TNK2 Q07912 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ AHR P35869 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ PTK6 Q13882 1/20 0.36
▸ AURKB Q96GD4 1/20 0.36
▸ IRAK4 Q9NWZ3 1/20 0.36
▸ USP28 Q96RU2 1/20 0.36
▸ USP25 Q9UHP3 1/20 0.36
▸ FSCN1 Q16658 1/20 0.36
▸ IKBKE Q14164 1/20 0.36
▸ TBK1 Q9UHD2 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16339445 0.97 LCK (0.41) LCKJAK3BTKTNK2MAPT
SCHEMBL16339353 0.95 IKBKE (0.39) LCKMAPTKMT2APTK6AURKB
SCHEMBL16340026 0.88 IRAK4 (0.38) IRAK4USP28FSCN1IKBKETBK1
SCHEMBL16339537 0.86 IKBKE (0.41) PTK6AURKBIRAK4FSCN1IKBKE
SCHEMBL16339370 0.85 HDAC1 (0.42) USP28USP25HTTBRPF1ZAP70
SCHEMBL16339136 0.83 IDH1 (0.37) LCKJAK3BTKTNK2NPC1
SCHEMBL25418681 0.82 MAPT (0.45) LCKJAK3BTKTNK2MAPT
SCHEMBL30422856 0.82 MAPT (0.45) LCKJAK3BTKTNK2MAPT
Hydrochloric Acid SCHEMBL30422569 0.82 MAPT (0.45) LCKJAK3BTKTNK2MAPT
SCHEMBL25439487 0.80 BCL6 (0.41) MAPTPTK6AURKBPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3013345-A2 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY F. Hoffmann-La Roche AG (CH) 2016-05-04 — — EP disclosed
WO-2014209841-A2 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY F. HOFFMANN-LA ROCHE AG (CH) 2014-12-31 — — WO disclosed
Send feedback